Background. Mortality associated with surgery for phaeochromocytoma has dramatically decreased over the last decades. Many factors contributed to the dramatic decline of the mortality rate, and the influence of an a-receptor blockade is unclear and has never been tested in a randomized trial. We evaluated intraoperative haemodynamic conditions and the incidence of complications in patients with and without a-receptor blockade undergoing surgery for catecholamine producing tumours. Methods. Haemodynamic conditions and perioperative complications were assessed in 110 patients with (B) and 166 without (N) a-receptor blockade. Data were analysed as a consecutive case series of 303 cases and subsequently via propensity score matching, and presented as mean and confidence interval (CI). Results. No difference in maximal intraoperative systolic arterial pressures (B ¼ 178 mm Hg (CI 169-187) vs N ¼ 185 mm Hg (CI 177-193; P ¼ 0.2542) and hypertensive episodes above 250 mm Hg were found (P ¼ 0.7474) for the closed case series. No major complications occurred. Propensity score matching (75 pairs) revealed a significant difference of 17 mm Hg in maximal intraoperative systolic bp for these selected pairs (P ¼ 0.024). Conclusions. Only a slight difference in mean maximal systolic arterial pressure was detected between patients with or without an a-receptor blockade. There was no difference in the incidence of excessive hypertensive episodes between groups and no major complications occurred. The basis for the general recommendation of perioperative a-receptor blockade for phaeochromocytoma surgery demands further study.
by significant improvements in diagnostics, surgery, and anaesthesia. Improvement in diagnostic techniques led to earlier diagnosis and more precise localization of tumours, 5 11 12 while surgical techniques developed from extensive abdominal to minimally invasive endoscopic procedures. 5 11 12-20 Moreover, development of invasive haemodynamic monitoring and improved management including the use of sodium-nitroprusside allowed better handling of acute hypertensive episodes intraoperatively.
The clinical impact of these factors has never been properly investigated. 1-3 21 Although pre-treatment with an a-receptor blocker has never been tested in a controlled randomized trial, this treatment is considered obligatory according to international guidelines. 1-3 7 10 12 However, many case series report intraoperative hypertensive episodes exceeding 200 mm Hg systolic arterial pressure despite use of an a-receptor blocker, which is not without side-effects. 7-10 17 22-23 In contrast, phaeochromocytoma surgery without a-receptor blockade has been successfully performed in selected patients without increased perioperative complications. 8 24 25 To explore the need for and effectiveness of perioperative a-receptor blockade, we performed an observational study and evaluated perioperative bp in 303 consecutive procedures in patients undergoing excision of chromaffin tumours with or without a-receptor blockade.
Methods
After approval by the local ethics committee (Board of Physicians € Arztekammer Nordrhein reg.no.: 2008126) 276 consecutive patients undergoing surgery between June 2008 and June 2016 gave informed written consent to have their data analysed in this observational study. Patients suffered from neurofibromatosis (n ¼ 5), von Hippel-Lindau disease (VHL; n ¼ 73), multiple endocrine neoplasia Type 2A (MEN 2A; n ¼ 42), or sporadic phaeochromocytoma and not further described entities (n ¼ 156). In 27 patients bilateral tumours were removed. In addition, 26 patients had extra-adrenal paraganglioma. There was no statistical difference (P ¼ 0.2488) in the pattern of catecholamines produced by the tumours with regard to the use of a-receptor blockade or not. Epinephrine was secreted by 24, norepinephrine in 45, and both in 33 tumours of patients with a-receptor blockade. In patients without a-receptor blockade, tumours produced epinephrine in 23, norepinephrine in 81, and both in 43. In 19 patients of the patients with a-receptor blockade and 35 of the patients without blockade, no elevated catecholamine concentrations could be detected. In 4 patients the tumour was regarded as incidental and the diagnosis of a phaeochromocytoma was missed until the time of surgery, therefore no catecholamine concentrations were determined.
Preoperative management
Whenever a physician or patient contacted our institution for referral of a patient with a catecholamine ¼ producing tumour, they were asked not to initiate a-receptor blockade. Over the last four yr many physicians and patients contacted our institution explicitly because they did not want a-receptor blockade. In case a-receptor blockade had already been started, it was continued until the day of surgery (n ¼ 121 
Anaesthesia and surgery
On the day of surgery after patients arrived in the anaesthesia induction room, non-invasive monitoring was applied and an arterial line was placed under local anaesthesia. Subsequently, general anaesthesia was induced with propofol, remifentanil, and mivacurium. After tracheal intubation, a 3-lumen central venous catheter was placed in the right or left internal jugular vein. Depending on the surgical approach, patients were placed in prone or supine position. Sodium nitroprusside was connected to one lumen of the central venous catheter and run at a minimal dose (1mg per h) to have it ready for rapid titration as needed. Anaesthesia was maintained with isoflurane in an oxygen/air mixture and continuous i.v. administration of remifentanil.Baseline systolic, highest systolic, and lowest mean arterial pressure, number and duration of systolic arterial pressure episodes > 250 mm Hg and episodes of mean arterial pressure < 60 mm Hg were assessed. Intraoperatively, the dose of sodium nitroprusside was individually increased if systolic arterial pressure exceeded 160 mm Hg. Esmolol was administered at the discretion of the responsible anaesthetist (n ¼ 21). Two-hundred-ninety operations were performed by the retroperitoneoscopic approach, four by the laparoscopic route, and one thoracoscopically. Eight patients were initially or secondarily operated upon by an open procedure (part of a multivisceral open resection n ¼ 5, conversion to open surgery n ¼ 2, paraganglioma in the wall of the bladder n ¼ 1). The surgical techniques of the retroperitoneoscopic and laparoscopic approach have been described in detail. 16 26 The incidence of complications potentially related to arterial hypertension such as myocardial infarction, acute congestive heart failure, pulmonary oedema, and cerebral stroke as a result of haemorrhage was assessed. Testing (troponin concentrations and postoperative ECG) was initiated in case of clinically suspected myocardial ischaemia and in patients with a history of myocardial ischaemia. Testing was not performed in asymptomatic patients without a history of myocardial ischaemia or a history of cardiac decompensation.
Data analysis
Data are presented as mean (95% confidence interval). The null hypothesis was no significant difference in maximal systolic arterial pressure between patients who received a-receptor Editor's key points
• Perioperative pharmacological blockade of a-receptors is routinely used in preparation for surgery for phaeochromocytoma, but its clinical impact has not been conclusively established.
• Arterial pressure and complications were analysed in a consecutive case series of 303 cases of surgery for phaeochromocytoma removal with or without perioperative a-receptor blockade.
• There was only a small difference in maximal systolic arterial pressure and no difference in complications with or without a-receptor blockade.
blockade as perioperative prophylaxis vs patients who received no prophylaxis. Data were analysed as a consecutive case series and following propensity score matching. 27 After linear regression, age, duration of surgery, tumour size, tumour aetiology, catecholamine production, and presence or absence of typical symptoms were used as matching criteria. To optimize matching, patients with open surgery (n ¼ 8) and patients, with preoperatively missed diagnosis of phaeochromocytoma (n ¼ 4) were not included. For patients with bilateral tumours, only the first operation was included ( Fig. 1 ).
CONSORT flow diagram
Assessed for eligibility (n=303 procedures in 276 patients)
Consecutive case series (no case excluded) In addition, correlation of individual doses of the respective a-receptor blocking agent and maximal systolic arterial pressure was evaluated. Data were analysed with Statview software (Version 5.0.1, SAS Institute inc., Cary NC, USA) and SAS (propensity score matching). After Kolmogorov-Smirnov tests for a normal distribution, data were tested by paired Student's t-test for continuous data and v 2 test for categorical variables.
Significant differences were assumed with P values < 0.05.
Results
None of the patients developed complications related to intraoperative hypertension. In particular no myocardial infarctions or signs of acute cardiac decompensation and acute insufficiency were detected.
Haemodynamic baseline before induction of anaesthesia did not differ between groups ( 
One operation had to be converted to an open procedure because of arterial bleeding that could not be managed endoscopically. Three patients developed CO 2 -embolism as a result of a lesion of the vena cava, which was closed endoscopically and resolved after 10 min of circulatory support with catecholamines without sequela. Five patients had accidental capnothorax, which was drained intraoperatively. Chest drains were removed at the end of the procedures. Postoperative recovery was uneventful in all patients except for one, allowing hospital discharge generally on the second to third postoperative day (range 2 -9 days). A 77 yr old normotensive patient developed an ischaemic stroke on the 3 rd postoperative day after an uneventful course during surgery. There were no significant differences in patient characteristics with or without a-receptor blockade (Table 1) , or in catecholamine concentrations of patients with increased catecholamine concentrations ( Table 2) . As a result of the differing reference values for upper normal concentrations from various laboratories, concentrations were expressed as percent of the upper normal values of the respective laboratory. Similarly, there was no difference in the aetiology of tumours and the pattern of catecholamine between patients with or without a-receptor blockade (P ¼ 0.0746 and P ¼ 0.2488, respectively). Both groups did not differ in operating time, blood loss, tumour size, and complication rate.
There was no difference in the number of preoperative antihypertensive drugs prescribed to the patients (Table 1 ). In patients without a-receptor blockade the prescription of a ß-receptor blocking agent (n ¼ 37) led to significantly higher baseline systolic arterial pressure (157 mm Hg (149-165)) compared with patients without ß-receptor blocking agents (n ¼ 129; 143 mm Hg (138-148); P ¼ 0.0003). There was no difference between patients with (n ¼ 47) or without (n ¼ 63) ß-receptor blocker in patients also with a-receptor blockade (with ß-blockade 144 mm Hg (138-150) vs without ß-blockade 144 mm Hg (139-149); P ¼ 0.9256). All tumours were histologically verified as phaeochromocytoma or paraganglioma.
Discussion
Intraoperative release of catecholamines from catecholamineproducing tumours can lead to haemodynamic instability and death. During almost a century of experience with phaeochromocytoma and paraganglioma surgery, advances in understanding and management of these tumours have led to a decrease in perioperative mortality from more than 40% to 3% or less.
1-4 6 11 12 The introduction of preoperative a-receptor blockade has been considered to contribute substantially to this success. 1-3 5 6-9 However, the effect of an a-receptor blockade has never been tested in a randomized trial. 1-3 7 10 28 In our study, independent of perioperative a-receptor blockade, intraoperative hypertensive episodes did not lead to cardiovascular complications. Intraoperative maximal systolic arterial pressure was not different with or without a-receptor blockade for the whole closed case series, but for the subgroup of patients matched according by propensity scoring. The incidence of systolic arterial pressure increases above 250 mm Hg was not affected by perioperative a-receptor blockade, while hypotensive episodes occurred more with a-receptor blockade. a-Receptor blockade can cause significant side-effects. Patients with coexisting cardio-or cerebrovascular diseases are at risk because of hypotension. It can take several weeks to establish a-receptor blockade and the effect exceeds the operation by several days, which can be responsible for a prolonged postoperative stay. 8 23 28 29 In reports, patients managed intraoperatively without pretreatment compared with patients with pretreatment with phenoxybenzamine or prazosin, there was no difference in the incidence of stroke and myocardial infarction. Based on experience gained with surgical treatment of chromaffin tumours in patients who stopped medical pre-treatment because of major side-effects and on incidentally discovered phaeochromocytomas (and therefore not pretreated), we felt that medical pre-treatment could be avoided at least in selected patients. Starting in 2008, all consecutive retroperitoneoscopic resections of catecholamine producing tumours were evaluated and data prospectively collected. Including consecutive cases without exception eliminates possible selection bias compared with studies where selected cases were evaluated. 30 Analysis of this consecutive case series showed no statistical difference in maximal intraoperative arterial pressure in patients with or without a-receptor blockade. In addition to the consecutive case series approach, we also analysed our data following propensity score matching, which revealed a significant difference in maximal systolic arterial pressure of this selected group of patients. Nevertheless, arterial pressure measurements of the group without a-receptor blockade were well within in the range of measurements of patients with a-receptor blockade reported in the literature. 7 10 13 28 29 31 32 No complications related to hypertensive episodes were found. The incidence of excessive hypertension with maximal systolic arterial pressure increase above 250 mm Hg was not different between groups. Moreover, we did not observe a correlation between the individual dose of a-receptor blocking agents with maximal systolic arterial pressure, although the doses administered were within the range described in the most recent guidelines. [1] [2] [3] Our data represent the largest number of patients without areceptor blockade reported to date, and demonstrate that phaeochromocytoma surgery without medical pre-treatment is feasible and safe. International guidelines for the perioperative treatment of patients with phaeochromocytoma and paraganglioma state that this treatment has never undergone scientific investigation. To statistically evaluate the effect of a-receptor blockade on mortality with a current mortality rate of 1%, a study of 2000 to 8000 patients would be required. Acquisition of blockade that required excessive doses of a-and b-receptor stimulation and even transcutaneous pacing to maintain stable haemodynamic conditions. Interpretation of our results is limited mainly by the low number of patients enrolled, because phaeochromocytoma is a rare disease, and by the lack of randomization. As pointed out above, the number of patients needed for evaluation of morbidity and mortality is so high that is seems unrealistic to accomplish such a study. For evaluation of maximal intraoperative arterial pressure the number of patients might be sufficient, but the meaning of a pressure difference of 10 or 20 mm Hg is clinically questionable in patients used to hypertensive episodes. Furthermore, our interpretation is limited by a lack of standardization in treatment. However, it represents usual clinical practice of all consecutive cases without bias as a result of selection by artificial study criteria.
We conclude that with modern minimally invasive surgical techniques, improved diagnostic tools for identification and localization of tumours, and highly effective short acting drugs to control haemodynamic conditions intraoperatively, one must question whether a time consuming, unreliable pre-treatment burdened with significant side-effects is still needed for all patients. Intraoperative hypertensive episodes occurred independently of perioperative a-receptor blockade. No major complications related to intraoperative haemodynamics with or without an a-receptor blockade were found. The general recommendation for perioperative a-receptor blockade as a prophylactic treatment for all patients with phaeochromocytoma and paraganglioma must therefore be questioned. The use of a-receptor blocking agents as a continuous treatment for excessive hypertension (for example in patients with malignant phaeochromocytoma or very large tumours) is not questioned by our evaluation.
